Vigil Neuroscience VIGL Stock
Vigil Neuroscience Price Chart
Vigil Neuroscience VIGL Financial and Trading Overview
| Vigil Neuroscience stock price | 1.56 USD |
| Previous Close | 9.26 USD |
| Open | 9.21 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 2200 |
| Day's Range | 9.07 - 10.34 USD |
| 52 Week Range | 2.25 - 16.77 USD |
| Volume | 61.56K USD |
| Avg. Volume | 30.98K USD |
| Market Cap | 356.85M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.07 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 19.71 USD |
VIGL Valuation Measures
| Enterprise Value | 180.65M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.0816326 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.0815988 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.435 |
Trading Information
Vigil Neuroscience Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 300.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 16.77 USD |
| 52 Week Low | 2.25 USD |
| 50-Day Moving Average | 9.42 USD |
| 200-Day Moving Average | 10.81 USD |
VIGL Share Statistics
| Avg. Volume (3 month) | 30.98K USD |
| Avg. Daily Volume (10-Days) | 52.56K USD |
| Shares Outstanding | 35.69M |
| Float | 6.88M |
| Short Ratio | 16.98 |
| % Held by Insiders | 10.15% |
| % Held by Institutions | 88.58% |
| Shares Short | 475.01K |
| Short % of Float | 2.33% |
| Short % of Shares Outstanding | 1.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.44% |
| Return on Equity (ttm) | -43.11% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -74202000 USD |
| Net Income Avi to Common (ttm) | -72766000 USD |
| Diluted EPS (ttm) | -1.86 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 164.48M USD |
| Total Cash Per Share (mrq) | 4.61 USD |
| Total Debt (mrq) | 14.69M USD |
| Total Debt/Equity (mrq) | 8.57 USD |
| Current Ratio (mrq) | 23.301 |
| Book Value Per Share (mrq) | 4.804 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -69191000 USD |
| Levered Free Cash Flow (ttm) | -41579376 USD |
Profile of Vigil Neuroscience
| Country | United States |
| State | MA |
| City | Watertown |
| Address | 100 Forge Road |
| ZIP | 02472 |
| Phone | (857) 254-4445 |
| Website | https://www.vigilneuro.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 59 |
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101, a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 proof-of-concept trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also conducting IND-enabling studies with a novel small molecule TREM2 agonist program to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Watertown, Massachusetts.
Q&A For Vigil Neuroscience Stock
What is a current VIGL stock price?
Vigil Neuroscience VIGL stock price today per share is 1.56 USD.
How to purchase Vigil Neuroscience stock?
You can buy VIGL shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vigil Neuroscience?
The stock symbol or ticker of Vigil Neuroscience is VIGL.
Which industry does the Vigil Neuroscience company belong to?
The Vigil Neuroscience industry is Biotechnology.
How many shares does Vigil Neuroscience have in circulation?
The max supply of Vigil Neuroscience shares is 46.67M.
What is Vigil Neuroscience Price to Earnings Ratio (PE Ratio)?
Vigil Neuroscience PE Ratio is now.
What was Vigil Neuroscience earnings per share over the trailing 12 months (TTM)?
Vigil Neuroscience EPS is -2.07 USD over the trailing 12 months.
Which sector does the Vigil Neuroscience company belong to?
The Vigil Neuroscience sector is Healthcare.
Vigil Neuroscience VIGL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}